ADD TO CART

CEREBROLYSIN - 60 mg

Legal Disclaimer
This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. BPC-157 ARG is not approved for medical use, human consumption, or as a therapeutic treatment in this context.

Product Details

  • Dosage: 500mcg per tablet

  • Quantity: 50 tablets per bottle

  • Form: Oral research tablets (Arginine salt version)

  • Packaging: Secure, sealed, tamper-proof container

  • Source: High-quality lab-grade peptide, third-party tested

  • Purity: ≥98% verified by HPLC and mass spectrometry

Overview of BPC-157 ARG’s Research Profile
BPC-157 ARG is an arginine-salt stabilized form of the well-known pentadecapeptide BPC-157, researched for its role in tissue regeneration, angiogenesis, and cellular repair. The arginine base form is often preferred for oral stability, making it suitable for studies into gastrointestinal absorption, peptide transport, and systemic activity in controlled environments.

BPC-157 ARG has been examined for its ability to support tendon, ligament, and vascular repair models, as well as its role in angiogenic signaling and collagen synthesis. The oral tablet format allows researchers to conduct long-term studies on peptide stability, systemic absorption, and regenerative biology.

Research Specifics

  • Tissue Regeneration Studies: Supports tendon and ligament repair in non-clinical models.

  • Angiogenesis Research: Promotes blood vessel formation and vascular repair mechanisms.

  • Collagen Synthesis: Enhances extracellular matrix development and healing studies.

  • Oxidative Stress Modulation: Investigated for protective effects against cellular stressors.

Key Features

  • Form: Oral research tablet (arginine-salt stabilized)

  • Dosage: 500mcg per unit

  • Quantity: 50 tablets per bottle

  • Sequence: Gly-Glu-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Ala-Gly-Leu-Val

  • Purity: ≥98% lab-verified, HPLC/MS

Potential Applications

  • Studies of tendon and ligament injury recovery models

  • Research into angiogenesis and vascular biology

  • Comparative evaluation of oral peptide stability and systemic activity

  • Modeling of gastrointestinal peptide absorption and delivery systems

Specifications
Each bottle of BPC-157 ARG oral tablets is securely packaged in tamper-evident containers to preserve stability during storage. Oral tablets are formulated for consistent dosage delivery and require no reconstitution.

Note

  • This product is intended solely for research and scientific purposes, including use by scientists, researchers, and other qualified individuals.

  • Images provided are for reference only and may differ from the actual product supplied.

  • Outcomes and applications are dependent on proper usage. Always adhere to required protocols and handle all materials responsibly. Misuse of this product is discouraged.

  • Reconstituting peptides with Bacteriostatic Water is a critical practice for achieving reliable research results.

Legal Disclaimer

This product is intended solely for laboratory and research purposes. They are not for human or animal use. Purchasers must comply with all applicable laws and regulations. By purchasing, you agree to indemnify and hold harmless our company from any claims arising from the handling or use of these products. Our liability is limited to the purchase price. Adopt all necessary safety precautions when handling the products. All product information and handling information is for informational/research purposes only.  This is governed under Canadian law.

Shipping across Canada, including but not limited to: British Columbia (Victoria, Vancouver, Surrey, Burnaby), Alberta (Edmonton, Calgary, Strathcona County), Saskatchewan (Regina, Saskatoon, Prince Albert), Manitoba (Winnipeg, Brandon), Ontario (Toronto, Ottawa, Mississauga, Hamilton), Quebec (Québec City, Montréal, Laval, Gatineau), New Brunswick (Fredericton, Saint John, Moncton), Nova Scotia (Halifax, Sydney), Prince Edward Island (Charlottetown, Summerside), Newfoundland and Labrador (St. John’s, Conception Bay South), Yukon (Whitehorse, Dawson City), Northwest Territories (Yellowknife, Hay River), Nunavut (Iqaluit, Arviat).